COVID-KOSHA
Home
Help
(current)
Comment
!
Note: Language translations may be imperfect
A model anti-pandemic portal for scientists & public
;
High priority articles (R1, Most articles most likely to be relevant):
Second priority articles (R2, Moderate portion of articles likely to be relevant):
Other articles (R3, Lesser portion of articles likely to be relevant):
Articles Not Curated -
Drug studies in animals
Last updated: 2024 Sep 18
Total hit(s): 948
S.No.
PMID
Ascending order
Descending order
Title
Ascending order
Descending order
Journal Name
Ascending order
Descending order
Publish Date
Ascending order
Descending order
Impact Factor
Ascending order
Descending order
Citations
Ascending order
Descending order
1
39182703
Diosmetin-7-O-beta-D-glucopyranoside from Pogostemonis Herba alleviated SARS-CoV-2-induced pneumonia by reshaping macrophage polarization and limiting viral replication.
J Ethnopharmacol
2025 Jan 10
6.8
1
2
38880868
Immunogenicity of intranasal vaccine based on SARS-CoV-2 spike protein during primary and booster immunizations in mice.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
3
38714327
Long-term stability and immunogenicity of lipid nanoparticle COVID-19 mRNA vaccine is affected by particle size.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
4
38156669
An epidemiological model for analysing pandemic trends of novel coronavirus transmission with optimal control.
J Biol Dyn
2024 Dec
4.1
1
5
39504352
Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infection.
Sci Transl Med
2024 Nov 6
11.64
1
6
39531923
SARS-CoV-2 main protease (M-pro) mutational profiling: An insight into mutation coldspots.
Comput Biol Med
2024 Nov 11
2.93
1
7
39102773
Engineering a NanoBiT biosensor for detecting angiotensin-converting enzyme-2 (hACE2) interaction with SARS-CoV-2 spike protein and screening the inhibitors to block hACE2 and spike interaction.
Biosens Bioelectron
2024 Nov 1
9.52
1
8
39424074
Replication capacity and susceptibility of nirmatrelvir-resistant mutants to next-generation Mpro inhibitors in a SARS-CoV-2 replicon system.
Antiviral Res
2024 Nov
4.12
1
9
39383917
Identification of a potent SARS-CoV-2 neutralizing nanobody targeting the receptor-binding domain of the spike protein.
Int J Biol Macromol
2024 Oct 9
4.94
1
10
39379362
Coronavirus envelope protein activates TMED10-mediated unconventional secretion of inflammatory factors.
Nat Commun
2024 Oct 8
11.8
1
11
39383977
Fluoroamphiphiles for enhancing immune response of subunit vaccine against SARS-CoV-2.
Eur J Pharm Biopharm
2024 Oct 7
1
12
39368535
Neuro-inflammatory pathways in COVID-19-induced central nervous system injury: Implications for prevention and treatment strategies.
Exp Neurol
2024 Oct 3
1
13
39477094
Oral 3CL protease inhibitor ensitrelvir suppressed SARS-CoV-2 shedding and infection in a hamster aerosol transmission model.
Antiviral Res
2024 Oct 29
4.12
1
14
39470198
Intranasal liposomal angiotensin-(1-7) administration reduces inflammation and viral load in the lungs during SARS-CoV-2 infection in K18-hACE2 transgenic mice.
Antimicrob Agents Chemother
2024 Oct 29
4.68
1
15
39489918
Enhanced mucosal SARS-CoV-2 immunity after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a combination adjuvant.
Mol Ther
2024 Oct 28
17
1
16
39484497
Long-term Immunity of a Microneedle Array Patch of SARS-CoV-2 S1 Protein Subunit Vaccine Irradiated by Gamma Rays in Mice.
bioRxiv
2024 Oct 25
- n/a -
1
17
39431894
Administration of Lactobacillus plantarum GUANKE alleviates SARS-CoV-2-induced pneumonia in mice.
Microbiol Spectr
2024 Oct 21
4.6
1
18
39414952
A self-adjuvanted VLPs-based Covid-19 vaccine proven versatile, safe, and highly protective.
Sci Rep
2024 Oct 16
4.12
1
19
39402337
FPR1 signaling aberrantly regulates S100A8/A9 production by CD14(+)FCN1(hi) macrophages and aggravates pulmonary pathology in severe COVID-19.
Commun Biol
2024 Oct 14
1
20
39387584
Mutation of a highly conserved isoleucine residue in loop 2 of several beta-coronavirus macrodomains indicates that enhanced ADP-ribose binding is detrimental for replication.
J Virol
2024 Oct 10
4.16
2
21
39357326
Identification of nitrile-containing isoquinoline-related natural product derivatives as coronavirus entry inhibitors in silico and in vitro.
Biomed Pharmacother
2024 Oct 1
3.83
1
22
39390688
Serum-derived bovine immunoglobulin treatment in COVID-19 is associated with faster resolution of symptoms: A randomized pilot clinical trial.
J Med Virol
2024 Oct
2.07
1
23
39349243
Development and validation of automated methods for COVID-19 PCR Master Mix preparation.
SLAS Technol
2024 Oct
2.13
1
24
39246209
Phytoconstituents as modulator of inflammatory pathways for COVID-19: A comprehensive review and recommendations.
Phytother Res
2024 Sep 9
7.5
1
25
39240093
Oral pharmacokinetics and efficacy of oral phospholipid remdesivir nucleoside prodrugs against SARS-CoV-2 in mice.
Antimicrob Agents Chemother
2024 Sep 6
4.68
1